Stifel Financial Corp (SF) Stock Price

97.89 ▲ +2.52 (+2.64%)
Open: 96.415 Vol: 0 Day's range: 96.28 - 98.325 Jun 16, 13:47 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
SF Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 97.89▼ 97.91▼ 97.87▼ 96.69▲ 95.41▲
MA10 97.94▼ 97.81▲ 96.76▲ 95.88▲ 92.76▲
MA20 98.00▼ 96.79▲ 96.48▲ 95.44▲ 95.33▲
MA50 97.80▲ 96.62▲ 96.55▲ 90.62▲ 97.97▼
MA100 96.81▲ 96.39▲ 95.38▲ 97.30▲ 84.30▲
MA200 96.44▲ 95.27▲ 95.37▲ 100.21▼ 74.13▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.057▼ 0.148▲ 0.236▲ 0.024▲ 0.580▲
RSI 46.734▼ 61.360▲ 59.676▲ 59.708▲ 51.790▲
STOCH 31.127     82.463▲ 80.744▲ 80.504▲ 79.365    
WILL %R -73.077     -15.856▲ -14.047▲ -7.751▲ -16.808▲
CCI -179.338▼ 46.770     94.071     114.933▲ 74.466    
Latest Filters Detected On SF
▲ RSI&MACD $SF MACD cross and RSI above 55 Set Alert
BBANDS $SF Bollinger Bands Contracting Set Alert
▲ MACD $SF MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $SF Price Crossed Above MA(26) Set Alert
MA $SF Price Crossed Above MA(7) Set Alert
▲ BREAK $SF Price Breaks 10 Days High Set Alert
Stifel Financial Corp News
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday, June 13, 2025 01:01 PM
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation ...
Chime Financial (CHYM) Opens at $43 in Nasdaq Debut After Pricing IPO at $27
Friday, June 13, 2025 08:38 AM
Chime Financial (CHYM, Financials), a digital banking app provider based in San Francisco, made its public market debut on Nasdaq Thursday, opening at $43 after pricing its initial public offering ...
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday, June 13, 2025 05:00 AM
Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral ...
SF historical stock data
date open high low close volume
16/06/25 96.415 98.325 96.28 97.82 252,539
13/06/25 95.36 96.72 94.35 95.37 668,373
12/06/25 95.21 97.04 94.61 96.98 389,509
11/06/25 96.79 97.685 96.21 96.68 471,855
10/06/25 96.58 97.32 96.12 96.59 349,441
09/06/25 97.50 97.63 95.7901 96.62 584,713
06/06/25 96.39 97.60 95.6894 96.53 504,557
05/06/25 93.33 95.38 92.82 94.82 911,276
04/06/25 94.17 95.25 93.28 93.35 632,900
03/06/25 93.10 94.62 92.36 94.08 455,163
Quote Details
52wk Low:73.27
52wk High:120.64
Vol:0
Avg Vol(3m):15M
1Y Chng:+17.28%
1M Chng:+9.86%
Add to Watch List
More Information
Index S&P 600
Market Cap. 9.93B